TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
NERV

Minerva Neurosciences Inc

Healthcare · Biotechnology

3.40$ +0.0% vs. previous close Closing price · As of: Sep 28, 2026

Statements

Balance Sheet

Minerva Neurosciences Inc (NERV) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 98 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet NERV
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
68 83 133 184 139 77 58 77 55 57 37 98
19 33 84 130 90 47 27 62 40 42 22 83
19 14 83 26 50 21 25 61 36 41 21 82
19 32 83 128 88 46 25 61 36 41 21 82
– – – – – – – – 3.1 – – –
0.0 0.0 0.0 0.0 – – – – -3.0 – – –
0.0 0.0 0.0 0.1 0.0 0.0 0.1 – 0.0 – – –
15 15 15 15 15 15 15 15 15 15 15 15
34 34 34 34 34 15 15 0.1 0.0 0.0 14,855 –
17 27 27 52 49 50 5.0 69 75 85 63 239
3.5 5.3 9.7 6.8 3.6 6.6 3.2 2.8 1.4 3.3 2.8 2.3
1.4 1.4 4.9 4.0 41,176 0.2 0.1 – – – – –
0.6 1.4 1.5 1.4 1.8 2.3 1.0 1.9 1.0 1.8 1.6 0.6
0.0 8.5 3.8 0.0 – – – – – – – –
51 55 106 132 90 28 53 8.0 -20 -28 -26 -141
-75 -102 -133 -164 -215 -287 -285 -335 -367 -397 -395 -689
2.3 2.9 3.9 4.7 4.8 4.9 5.1 5.3 5.3 6.5 7.6 8.5

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?